167 related articles for article (PubMed ID: 36531826)
21. Design, Synthesis, and Biological Evaluation of quinoxaline bearing tetrahydropyridine derivatives as anticancer, antioxidant, and anti-tubercular agents.
Pavale G; Acharya P; Korgavkar N; Ramana MMV
Curr Comput Aided Drug Des; 2022 Aug; ():. PubMed ID: 35927819
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
23. The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles.
Reddyrajula R; Dalimba U
Bioorg Med Chem Lett; 2020 Jan; 30(2):126846. PubMed ID: 31839540
[TBL] [Abstract][Full Text] [Related]
24. Some Thiazole Derivatives Combined with Different Heterocycles: Cytotoxicity Evaluation and Apoptosis Inducing Studies.
Yurttaş L; Demir B; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1115-1121. PubMed ID: 29595114
[TBL] [Abstract][Full Text] [Related]
25. Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents.
Ahmed EA; Mohamed MFA; Omran OA
RSC Adv; 2022 Sep; 12(39):25204-25216. PubMed ID: 36199335
[TBL] [Abstract][Full Text] [Related]
26. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
Vilchèze C; Jacobs WR
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
[TBL] [Abstract][Full Text] [Related]
28. Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues.
Nandikolla A; Mahadu Khetmalis Y; Mahalakshmi Naidu K; Karan Kumar B; Murugesan S; Chandra Sekhar KVG
Toxicol In Vitro; 2022 Aug; 82():105370. PubMed ID: 35489549
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
Srour AM; Ahmed NS; Abd El-Karim SS; Anwar MM; El-Hallouty SM
Bioorg Med Chem; 2020 Sep; 28(18):115657. PubMed ID: 32828424
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of phenyl quinoline phenol derivatives as COX-2 inhibitors; an approach to emergent the small molecules as the anti-inflammatory and analgesic therapeutics.
Manikandan A; Ravichandran S; Sathiyanarayanan KI; Sivakumar A
Inflammopharmacology; 2017 Dec; 25(6):621-631. PubMed ID: 28378280
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-
Khetmalis YM; Chitti S; Umarani Wunnava A; Karan Kumar B; Murali Krishna Kumar M; Murugesan S; Chandra Sekhar KVG
RSC Med Chem; 2022 Mar; 13(3):327-342. PubMed ID: 35434623
[TBL] [Abstract][Full Text] [Related]
32. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
[TBL] [Abstract][Full Text] [Related]
33. Preparation, biological evaluation and molecular docking study of imidazolyl dihydropyrimidines as potential Mycobacterium tuberculosis dihydrofolate reductase inhibitors.
Desai NC; Trivedi AR; Khedkar VM
Bioorg Med Chem Lett; 2016 Aug; 26(16):4030-5. PubMed ID: 27397497
[TBL] [Abstract][Full Text] [Related]
34. Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
Reddyrajula R; Dalimba U; Madan Kumar S
Eur J Med Chem; 2019 Apr; 168():263-282. PubMed ID: 30822714
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound mediated efficient synthesis of new 4-oxoquinazolin-3(4H)-yl)furan-2-carboxamides as potent tyrosinase inhibitors: Mechanistic approach through chemoinformatics and molecular docking studies.
Dige NC; Mahajan PG; Raza H; Hassan M; Vanjare BD; Hong H; Hwan Lee K; Latip J; Seo SY
Bioorg Chem; 2019 Nov; 92():103201. PubMed ID: 31445195
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Cordeiro R; Kachroo M
Bioorg Med Chem Lett; 2020 Dec; 30(24):127655. PubMed ID: 33130292
[TBL] [Abstract][Full Text] [Related]
38. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel oxindole analogs as antitubercular agents.
Khetmalis YM; Sangeetha GP; Chandu A; Swati ; Murugesan S; Sharma V; Kumar MM; Kondapalli VG
Future Med Chem; 2023 Aug; 15(15):1323-1342. PubMed ID: 37610851
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]